Novartis | NVS - PE Price to Earnings

Stock Price
154.85
Daily Change
0.11 0.07%
Monthly
-6.37%
Yearly
37.94%
Q1 Forecast
149.59

Novartis reported 16.05 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Amgen 25.31 15.82 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bausch Health Companies 6.98 0.41 Dec/2025
Biogen 14.02 4.63 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Corcept Therapeutics 41.9 52.28 Dec/2025
Drreddys Laboratories 18.27 0.84 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Glaxosmithkline 11.93 6.46 Sep/2025
J&J 23.62 0.86 Dec/2025
Merck 13.92 5.08 Dec/2025
Novartis 15.74 0.15 Sep/2025
Novartis 16.05 2.92 Sep/2025
Pacira 52.68 23.44 Dec/2025
Perrigo 58.96 24.65 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Phibro Animal Health 13.82 4.04 Dec/2025
Prestige Brands 15.31 3.1 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Sanofi 15.75 1.53 Dec/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
Zoetis 20.42 2.84 Dec/2025